Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial

Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial

(2021) Kristin B Highland et al.   Lancet Respiratory Medicine

Tocilizumab Prevents Progression of Early Systemic Sclerosis Associated Interstitial Lung Disease

(2021) David Roofeh et al.   Arthritis & Rheumatology

Treatment for systemic sclerosis-associated interstitial lung disease

(2021) David Roofeh et al.   CURRENT OPINION IN RHEUMATOLOGY

Systemic sclerosis-associated interstitial lung disease

(2020) Apostolos Perelas et al.   Lancet Respiratory Medicine

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

(2020) Anna-Maria Hoffmann-Vold et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis−Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double‐Blind, Placebo‐Controlled Trial

(2020) Toby M. Maher et al.   Arthritis & Rheumatology

Pulmonary physiology is poorly associated with radiological extent of disease in systemic sclerosis-associated interstitial lung disease

(2019) Amrit Jhajj et al.   EUROPEAN RESPIRATORY JOURNAL

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

(2019) Oliver Distler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort

(2019) Anna-Maria Hoffmann-Vold et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Reliability and Minimal Clinically Important Differences of FVC. Results from the Scleroderma Lung Studies (SLS-I and SLS-II)

(2018) Suzanne Kafaja et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts

(2018) Elizabeth R Volkmann et al.   ANNALS OF THE RHEUMATIC DISEASES

Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease

(2017) Noémie Le Gouellec et al.   PLoS One

Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis

(2017) Nicole S. Goh et al.   Arthritis & Rheumatology

Prediction of Pulmonary Complications and Long-Term Survival in Systemic Sclerosis

(2014) Svetlana I. Nihtyanova et al.   Arthritis & Rheumatology

2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

(2013) Frank van den Hoogen et al.   ARTHRITIS AND RHEUMATISM

Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease

(2012) O. A. Moore et al.   RHEUMATOLOGY

Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: Analysis of the Scleroderma Lung Study Placebo Group

(2011) Dinesh Khanna et al.   ARTHRITIS AND RHEUMATISM

Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease

(2011) Michael D. Roth et al.   ARTHRITIS AND RHEUMATISM

Interstitial Lung Disease in Systemic Sclerosis

(2008) Nicole S. L. Goh et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE